Archived Grants
















								To Oklahoma companies and researchers who may be interested in commercial applications of Nanotechnology: We would like to know which companies and researchers in Oklahoma are interested in pursuing the utilization of the emerging field of nanotechnology to improve their existing products or create new products. Short workshops to provide a briefing opportunity about nanotechnology and how it may benefit Oklahoma companies will be held in Oklahoma City and Tulsa on Oct. 19th and 25th respectively as noted below. Attached is an opportunity for companies and researchers to present a White Paper (Statement of Intent) regarding nanotechnology commercialization ideas. The Oklahoma Alliance for Manufacturing Excellence has been selected by the Oklahoma Center for the Advancement of Science and Technology (OCAST) to operate the Oklahoma Nanotechnology Applications Service (ONAS). Read More View White Paper Expired Grants National Science Foundation (NSF) - NSF is soliciting proposals for a program on collaborative research and education in the area of active nanostructures and nanosystems, and on the long-term social change associated with these innovations. This program seeks to support fundamental research and catalyze synergistic science and engineering research and education in several emerging areas of nanoscale science and technology. Approximately $42 million is expected to be available for 70 awards. Proposals for Nanoscale Interdisciplinary Research Teams may be submitted by a single organization or a group of organizations consisting of a lead organization in partnership with one or more partner organizations. Nanoscale Exploratory Research proposals may be submitted by U.S. academic institutions with undergraduate and/or Ph.D. programs in disciplines usually supported by NSF. All proposals are due Nov. 29, 2005. More information is available at: http://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf05610 NSF is soliciting proposals for its Bioengineering and Bioinformatics Summer Institutes Program. This program is designed to provide undergraduate and early-stage graduate students majoring in the biological sciences, computer sciences, engineering, mathematics, and physical sciences with well-planned, interdisciplinary bioengineering or bioinformatics research and education experiences in active 'Summer Institutes', thereby increasing the number of individuals pursuing careers in bioengineering and bioinformatics at the graduate level and beyond. Eligibility is limited to U.S. academic institutions that have strong interdisciplinary research programs and a training infrastructure to support the didactic part of the summer program. Students who are U.S. citizens or permanent residents of the U.S. or its possessions must have completed their sophomore year, if undergraduates, or be within the first two years of entry into their graduate program, if graduates. Approximately $2 million is expected to be available for 12-15 awards. Proposals are due Nov. 29, 2005. More information is available at: http://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf05611 NANOSCIENCE AND NANOTECHNOLOGY IN BIOLOGY AND MEDICINE Release Date: 12/12/2002 Expiration Date: 08/19/2006 Issuing Organization: NIDCR Announcement Number: PAR-03-045 Summary: This Program Announcement (PA), issued as an initiative of the trans- NIH Bioengineering Consortium (BECON), is aimed at enhancing nanoscience and nanotechnology research approaches that have the potential to make valuable contributions to biology and medicine. Nanoscience and nanotechnology refer to research at the atomic, molecular or macromolecular levels, at the length scale of approximately 1 - 100 nanometers. The purpose of this initiative is to stimulate cross-cutting, integrative research in these fields of science and technology. In particular, this initiative invites research on: i) the creation and use of structures, devices and systems that have novel properties and functions because of their small size, that may be used to achieve a fundamental understanding of biological processes and /or contribute to disease detection, therapy, or prevention; ii) conception and fabrication of devices, that will effectively detect and analyze nanoscale entities of relevance to biomedicine; and iii) the study of biological systems at the nanoscale for the explicit purpose of using that information to develop nanotechnologies and nanostructured materials that will in turn benefit biology and medicine. It is anticipated that the research projects that will be most responsive to this PA will require interdisciplinary collaborations among investigators with expertise in a range of disciplines, including but not limited to engineering, physics, chemistry, cellular and molecular biology, materials and computer science. Applications submitted in response to this PA may propose hypothesis-driven, discovery-driven, developmental, or design-directed research. More Info Ruth L. Kirschstein NRSA Fellowships in Cancer Nanotechnology Research Release Date: 07/13/2005 Expiration Date: 11/17/2005 Issuing Organization: NCI Announcement Number: RFA-CA-06-010 Summary: This RFA supports the training of individuals from the basic, biomedical, clinical, and information sciences and engineering who are pursuing research that applies nanotechnology development and application for the prevention, detection, diagnosis, or treatment of cancer. This funding opportunity will use Ruth L. Kirschstein National Research Service Awards (Kirschstein-NRSA) to support individual postdoctoral fellowships (F32) and senior fellowships (F33). The NCI intends to commit approximately $15.5M dollars over 3 years to fund a total of 36 new fellowships in response to this RFA (approximately 18 for each mechanism). The total amount of funds committed for F32 fellowships for FY 2006 is approximately $0.75 M. The total for F33 fellowships and supplements for FY 2006 is approximately $4.42M. An applicant may request a project period of up to 3 years for F32 (stipend levels depend on full years of post-degree experience at the time of award, and include an institutional allowance; both amounts are determined yearly by Congress) and 2 years for F33 fellowships (stipend not to exceed the level of Kirschstein-NRSA stipend support for individuals with more than 7 years experience). An applicant may request a project period of up to 3 years for F32 and 2 years for F33 fellowships. The anticipated start date for fellowship awards is July 2006, and funding will terminate no later than September 2009. Eligible supporting organizations include for-profit or non-profit organizations, public or private institutions (such as universities, colleges, hospitals, and laboratories), units of State government, units of local government, eligible agencies of the Federal government, and domestic or foreign institutions/organizations. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with his or her institution and mentor to develop an application for support. By the time of award, candidates for the F32 or F33 fellowship must be citizens or non-citizen nationals of the United States or must have been lawfully admitted to the United States for Permanent Residence (i.e., possess a currently valid Alien Registration Receipt Card I-551 or other legal verification of such status). Before a Kirschstein-NRSA F32 postdoctoral fellowship or F33 senior fellowship can be activated, the individual must have received a Ph.D., M.D., D.O., D.C., D.D.S., D.V.M., O.D., D.P.M., Sc.D., Eng.D., Dr. P.H., D.N.S., N.D., Pharm.D., D.S.W., Psy.D., or equivalent doctoral degree from an accredited domestic or foreign institution. Certification by an authorized official of the degree-granting institution that all degree requirements have been met is also acceptable. In addition, applicants for a Kirschstein-NRSA F33 senior fellowship must be at least 7 years beyond one of the above qualifying degrees, have had at least 7 years of post-degree relevant research or professional experience, and have established an independent research career. More Info Technology Development for Biomedical Applications Release Date: 02/04/2005 Expiration Date: I0/20/2005 Issuing Organization: NCRR Announcement Number: RFA-RR-05-001 Summary: The purpose of this request for applications (RFA) is to invite innovative applications for (1) the development of new and improved instruments or devices, (2) the development of new methodologies using existing instruments, or (3) the development of software related to instrumentation. NCRR intends to commit approximately $1 million to this program in FY 2006. This amount will allow the funding of five to eight new grants. Applications will use either the R21 or the R21/R33 mechanisms. Eligible organizations include for-profit or non-profit institutions, public or private institutions, units of state and local government, domestic institutions, and eligible agencies of the Federal government. Applicants from for-profit organizations are strongly encouraged to contact program staff before submitting an application. Eligible principal investigators include any individual with the skills, knowledge, and resources necessary to carry out the proposed research. There is no limit on the number of scientifically different applications from an individual or an institution. More Info BIOENGINEERING RESEARCH PARTNERSHIPS Release Date: 11/18/2003 Expiration Date: 05/23/2006 Issuing Organization: NIBIB Announcement Number: PAR-04-023 Summary: Participating Institutes and Centers (ICs) of the National Institutes of Health (NIH) invite applications for R01 awards to support Bioengineering Research Partnerships (BRPs) for basic, applied, and translational multi- disciplinary research that addresses important biological or medical research problems. In the context of this program, a partnership is a multi- disciplinary research team that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior. The partnership must include appropriate bioengineering or allied quantitative sciences in combination with biomedical and/or clinical components. The Principal Investigator (PI) also serves as the project manager and must be capable of leading the proposed effort. A BRP may propose design-directed, developmental, discovery-driven, or hypothesis-driven research at universities, national laboratories, medical schools, large or small businesses, or other public and private entities or combinations of these entities. It is expected that a BRP will have a well-defined goal or deliverable that will be achieved based on objective milestones specified in the initial application. On October 11, 2001, the NIH issued a related program announcement (PA) PA-02-011 (http://grants.nih.gov/grants/guide/pa-files/PA-02-011.html) for Bioengineering Research Grants (BRGs). The BRGs differ from the BRPs in that the research will be performed in a single laboratory, by a single investigator, or by a small group of investigators. On January 16, 2003, the NIH issued another related program announcement PA-03-058 (http://grants.nih.gov/grants/guide/pa-files/PA-03-058.html) for Exploratory/Developmental (R21) Bioengineering Research Grants (EBRG). The EBRGs differ from the BRPs in that (1) the research will be performed in a single laboratory, by a single investigator, or by a small group of investigators and (2) the projects are high-risk/high-payoff in nature (R21 mechanism) as compared to the R01-type grants supported by the BRP program. More Info EMERGING TECHNOLOGIES FOR THE STUDY OF REPRODUCTIVE NEUROENDOCRINOLOGY Release Date: 03/19/2003 Expiration Date: 03/15/2006 Issuing Organization: NICHD Announcement Number: PA-03-079 Summary: The National Institute of Child Health and Human Development (NICHD) and the National Institute of Neurological Disorders and Stroke (NINDS) invite applications dealing with nervous system control of reproduction. The purpose of this PA is to stimulate the development of new technologies and the application of existing innovative technologies to answer questions regarding the neuroendocrine control of reproduction that, up to this point, could not be answered due to limitations in technology. Answers to these questions are particularly critical for human reproduction given the increased evidence for altered neuroendocrine function as an etiological underpinning for certain reproductive diseases and disorders. More Info CUTTING-EDGE BASIC RESEARCH AWARDS (CEBRA) Release Date: 10/30/2002 Expiration Date: 10/05/2005 Issuing Organization: NIDA Announcement Number: PAR-03-017 Summary: The National Institute on Drug Abuse (NIDA) invites applications for Cutting- Edge Basic Research Awards (CEBRA) to foster highly innovative or conceptually creative research that advances our understanding of drug abuse and addiction and how to prevent and treat them. The CEBRA is a new mechanism designed by NIDA to foster novel research approaches and represents the high priority placed by NIDA on identifying such research. NIDA currently supports a great deal of innovative biomedical research. The CEBRA, however, is specifically designed to support research that is high- risk and potentially high-impact and that is underrepresented or not included in NIDA's current portfolio. It is not intended for incremental research or research extending ongoing programs. It is aimed at experienced drug abuse research investigators who wish to develop or adapt new methods or techniques and at new investigators or scientists with expertise in fields other than drug abuse who wish to establish innovative programs in drug abuse research. NIDA's CEBRA program will provide rapid review and funding decisions. The R21 mechanism allows support for projects in the early, first stages of development (Stage I) where there are little or no preliminary data available, but which have a strong rationale and conceptual framework. Successful Stage I applicants will be eligible to apply for a Stage II award (R01) that will support the innovative research initiated in Stage I (R21). Specific features of the CEBRA include: o Focus on innovation. o Transition from feasibility stage to development stage. o Expedited review convened by NIDA for Stage I submissions. More Info BIOENGINEERING RESEARCH GRANTS Release Date: 10/11/2001 Expiration Date: 10/31/2005 Issuing Organization: NIBIB Announcement Number: PA-02-011 Summary: Participating Institutes and Centers (ICs) of the National Institutes of Health (NIH) invite applications for R01 awards to support Bioengineering Research Grants (BRGs) for basic and applied multi-disciplinary research that addresses important biological or medical research problems. The BRGs support multi- disciplinary research performed in a single laboratory or by a small number of investigators that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior. A BRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research at universities, national laboratories, medical schools, large or small businesses, or other public and private entities. More Info













	ooni ooni oni ooni ooni ooni ooni ooni ooni ooni ooni ooni ooni ooni ooni ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni ooni oo oo ooni iooni ooni ooni ooni ooni ooni ooni ooni oni oni oni oni oni oni oni oni oni oni oni oni